Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
0.9832
+0.0228 (2.37%)
Aug 7, 2026, 12:47 PM EDT - Market open
CRDF's stock price has decreased by -59.87% in the past year and price targets may not have had time to catch up.
Cardiff Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lucid Capital | Lucid Capital | Buy Maintains $10 → $4 | Buy | Maintains | $10 → $4 | +306.83% | Jun 5, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 4, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 3, 2026 |
| Craig-Hallum | Craig-Hallum | Hold Downgrades $2 | Hold | Downgrades | $2 | +103.42% | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 1, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $12 | Buy | Reiterates | $12 | +1,120.50% | May 22, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $6 | Buy | Reiterates | $6 | +510.25% | May 15, 2026 |